Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations
Azadeh C. Bashi(AstraZeneca (United Kingdom)), Mathew J. Garnett(Wellcome Sanger Institute)
Cited by 35
Related Papers
Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics
|Nature Communications|2018|335
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
|Cancer Discovery|2021|113
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
|Cancer Discovery|2024|48
A suspension technique for efficient large-scale cancer organoid culturing and perturbation screens
|Scientific Reports|2022|42